活化白细胞黏附分子在乳腺癌中的研究进展

doi:10.11904/j.issn.1002-3070.2024.01.007

Abstract

Abstract: Breast cancer is the most common cancer among women worldwide,and it is also one of the most important diseases that cause women′s death.The study of tumor related biomarkers and therapeutic targets has become a hot topic in the field of cancer.Studies have found that activated leukocyte cell adhesion molecule(ALCAM)plays an important role in the occurrence and development of breast cancer,and it is related to the prognosis of breast cancer patients.This article reviews the molecular characteristics of ALCAM,the correlation between ALCAM expression and breast cancer clinical feature and prognosis,and the research and application of ALCAM as a target for clinical diagnosis and treatment of breast cancer.

Key words: Activated leukocyte cell adhesion molecules, Breast cancer, Tumor biomarkers

CLC Number:

R737.9

XIE Junling. Research progress of activated leukocyte adhesion molecule in breast cancer[J]. Journal of Practical Oncology, 2024, 38(1): 45-49.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2024.01.007

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2024/V38/I1/45

References

1 Yang YM,Ye L,Ruge F,et al.Activated leukocyte cell adhesion Molecule(ALCAM),a potential′Seed′and′Soil′receptor in the peritoneal metastasis of gastrointestinal cancers[J].Int J Mol Sci,2023,24(1):876-897.
2 von Lersner A,Droesen L,Zijlstra A.Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166[J].Clin Exp Metastasis,2019,36(2):87-95.
3 Münsterberg J,Loreth D,Brylka,et al.ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium[J].Neuro Oncol,2020,22(7):955-966.
4 Chalmers SA,Ayilam Ramachandran R,Garcia SJ,et al.The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses[J].J Clin Invest,2022,132(1):e147334.
5 Cho WJ,Mittal SK,Chauhan SK.Mesenchymal stromal cellssuppress T-cell-mediated delayed-type hypersensitivity via ALCAM-CD6 interaction[J].Stem Cells Transl Med,2023,12(4):221-233.
6 Yang Y,Sanders AJ,Dou QP,et al.The Clinical and theranostic values of activated leukocyte cell adhesion molecule(ALCAM)/CD166 in human solid cancers[J].Cancers(Basel),2021,13(20):5187-5214.
7 Darvishi B,Boroumandieh S,Majidzadeh-AK,et al.The role of activated leukocyte cell adhesion molecule(ALCAM)in cancer progression,invasion,metastasis and recurrence:A novel cancer stem cell marker and tumor-specific prognostic marker.Exp Mol Pathol[J].2020,115:104443-104451.
8 Ferragut F,Vachetta VS,Troncoso MF,et al.ALCAM/CD166:A pleiotropic mediator of cell adhesion,stemness and cancer progression[J].Cytokine Growth Factor Rev,2021,61:27-37.
9 Bartolomé RA,Pintado-Berninches L,Jaén M,et al.SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166[J].Oncogene,2020,39(38):6085-6098.
10 Chen X,Liang R,Lin H,et al.CD166 promotes cancer stem cell-like phenotype via the EGFR/ERK1/2 pathway in the nasopharyngeal carcinoma cell line CNE-2R[J].Life Sci,2021,267:118983-118990.
11 Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.
12 李福程,贾斯媛,巴玉玲,等.免疫检查点抑制剂在早期乳腺癌新辅助治疗中的研究进展[J].实用肿瘤学杂志,2023,37(4):367-371.
13 Hebron KE,Li EY,Arnold Egloff SA,et al.Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis[J].Sci Rep,2018,8(1):3208-3222.
14 Iwagishi R,Tanaka R,Seto M,et al.Negatively charged amino acids in the stalk region of membrane proteins reduce ectodomain shedding[J].J Biol Chem,2020,295(35):12343-12352.
15 King JA,Ofori-Acquah SF,Stevens T,et al.Activated leukocyte cell adhesion molecule in breast cancer:prognostic indicator[J].Breast Cancer Res,2004,6(5):478-487.
16 Davies SR,Dent C,Watkins G,et al.Expression of the cell to cell adhesion molecule,ALCAM,in breast cancer patients and the potential link with skeletal metastasis[J].Oncol Rep,2008,19(2):555-561.
17 Ihnen M,Müller V,Wirtz RM,et al.Predictive impact of activated leukocyte cell adhesion molecule(ALCAM/CD166)in breast cancer[J].Breast Cancer Res Treat,2008,112(3):419-427.
18 Ihnen M,Wirtz RM,Kalogeras KT,et al.Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2-and ER-negative breast cancer[J].Br J Cancer,2010,28;103(7):1048-1056.
19 Bartolomé RA,Pintado-Berninches L,Jaén M,et al.SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166[J].Oncogene,2020,39(38):6085-6098.
20 Yang Y,Ma Y,Gao H,et al.A novel HDGF-ALCAM axis promotes the metastasis of Ewing sarcoma via regulating the GTPases signaling pathway[J].Oncogene,2021,40(4):731-745.
21 Burkhardt M,Mayordomo E,Winzer KJ,et al.Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer[J].J Clin Pathol,2006,59(4):403-409.
22 Burandt E,Bari Noubar T,Lebeau A,et al.Loss of ALCAM expression is linked to adverse phenotype and poor prognosis in breast cancer:a TMA-based immunohistochemical study on 2,197 breast cancer patients[J].Oncol Rep,2014,32(6):2628-2634.
23 Tan F,Mosunjac M,Adams AL,et al.Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer[J].BMC Cancer,2014,25;14:715-722.
24 Piao D,Jiang T,Liu G,et al.Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer[J].Mol Biol Rep,2012,39(1):661-668.
25 Renard HF,Tyckaert F,Lo Giudice C,et al.Endophilin-A3 and Galectin-8 control the clathrin-independent endocytosis of CD166[J].Nat Commun,2020,11(1):1457-1469.
26 Kulasingam V,Zheng Y,Soosaipillai A,et al.Activated leukocyte cell adhesion molecule:a novel biomarker for breast cancer[J].Int J Cancer,2009,25(1):9-14.
27 Al-Shehri FS,Abd El Azeem EM.Activated leukocyte cell adhesion molecule(ALCAM)in saudi breast cancer patients as prognostic and predictive indicator[J].Breast Cancer(Auckl),2015,23(9):81-86.
28 Zarghami N,Soto MS,Perez-Balderas F,et al.A novel molecular magnetic resonance imaging agent targeting activated leukocyte cell adhesion molecule as demonstrated in mouse brain metastasis models[J].J Cereb Blood Flow Metab,2021,41(7):1592-1607.
29 Darvishi B,Salehi M,Boroumandieh S,et al.Dual in vitro invasion/migration suppressing and tamoxifen response modulating effects of a recombinant anti-ALCAM scFv on breast cancer cells[J].Cell Biochem Funct,2020,38(5):651-659.
30 Boni V,Fidler MJ,Arkenau HT,et al.Praluzatamab ravtansine,a CD166-targeting antibody-drug conjugate,in patients with advanced solid tumors:An open-label phase Ⅰ/Ⅱ Trial[J].Clin Cancer Res,2022,28(10):2020-2029.

[1]	ZHENG Pengfei, DONG Liangpeng, GAO Yanxin, ZHANG Yifu, QIN Shuang. Effect of interleukin-38 to CD8⁺T lymphocyte function in patients with breast cancer [J]. Journal of Practical Oncology, 2024, 38(1): 30-36.
[2]	FENG Churan, CAO Jianzhao, CHEN Ziyin, ZHANG Daxin, LU Hailing. Research progress on radiation-induced cardiac injury in breast cancer and its preventive measures [J]. Journal of Practical Oncology, 2023, 37(6): 513-518.
[3]	ZHAO Shilu, PANG Da. Bioinformatics screening and analysis of prognostic genes in breast cancer [J]. Journal of Practical Oncology, 2023, 37(5): 422-428.
[4]	CHU Sitong, XU Qingyong. Research progress on immunotherapy resistance mechanisms of triple-negative breast cancer [J]. Journal of Practical Oncology, 2023, 37(5): 449-453.
[5]	WANG Xinping, ZHANG Ziyun, WANG Xuedong. Research progress on the roles of non-coding RNA in chemotherapy resistance of breast cancer [J]. Journal of Practical Oncology, 2023, 37(5): 454-458.
[6]	LU Hongnan, XIA Bingshu, QIAO Kun, ZHANG Shiyuan, HUANG Yuanxi, LU Xiangshi. Relationship between GAS1,immunotherapy and drug sensitivity in breast cancer [J]. Journal of Practical Oncology, 2023, 37(4): 351-359.
[7]	CHEN Fei, WANG Ying, ZENG Chuanqin. Expression of B7-H4 in breast cancer tissues and its correlation with axillary lymph node metastasis in patients after neoadjuvant chemotherapy [J]. Journal of Practical Oncology, 2023, 37(4): 360-366.
[8]	LI Fucheng, JIA Siyuan, BA Yuling, LUO Danli, XIAO Min. Research progress of immune checkpoint inhibitors in neoadjuvant therapy of early breast cancer [J]. Journal of Practical Oncology, 2023, 37(4): 367-371.
[9]	MA Yanling, QIAN Liting, WEI Donghua, YIN Huiping, Zhang Juan, ZHANG Xiaopeng. Analysis of screening rate and influencing factors of high-risk population of breast cancer in Hefei city of Anhui province from 2014 to 2017 [J]. Journal of Practical Oncology, 2023, 37(3): 200-206.
[10]	SUI Shiyao, ZHENG Wei, YANG Zihan, PANG Da. LncRNA SNHG4 inhibits ferroptosis of breast cancer through EP300-SNHG4-GPX4 axis [J]. Journal of Practical Oncology, 2023, 37(3): 215-223.
[11]	ZHANG Qinghuai, HAN Ameng, YANG Sen, LI Xiumei, ZHAO Jianxin, ZHANG Yanqiu. A comparative study of five radiotherapy techniques for breast cancer patients after breast-conserving surgery [J]. Journal of Practical Oncology, 2023, 37(3): 224-229.
[12]	YANG Shuai, WANG Xinheng, WU Jiale, FU Zitong, WEI Bo, YANG Lingbing, XU Shouping. Research progress of single-cell sequencing technology in breast cancer [J]. Journal of Practical Oncology, 2023, 37(3): 287-292.
[13]	ZHANG Xin, WU Xianmei, LI Hong, LIU Xiaozhou, KONG Dewen, CHEN Zhuo. The disease burden of breast cancer attributed to metabolic risk factors in the Chinese female population,from 1990 to 2019 [J]. Journal of Practical Oncology, 2023, 37(2): 107-111.
[14]	LIU Xinxin, MA Xiyuan, MIU Meiqi, WANG Yuqing, CHEN Jing. Research progress on the role of IL-6 and its receptor in the treatment of breast cancer [J]. Journal of Practical Oncology, 2023, 37(2): 149-154.
[15]	FENG Chengtian, HUANG Furong, JIANG Yongdong. Research progress of lipid metabolism on the mechanism of drug resistance to trastuzumab therapy in breast cancer [J]. Journal of Practical Oncology, 2023, 37(2): 155-159.

Research progress of activated leukocyte adhesion molecule in breast cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments